Keystone Biologics Advisory works collaboratively with clients to prepare for FDA pre-IND meetings. Our involvement includes understanding the drug development program, review of CMC documentation in relation to regulatory readiness, advising on the critical issues to address with the FDA and regulatory strategy. This ensures the timely and strategic engagement with the FDA to prepare for pre-IND meeting.
Keystone Biologics Advisory works collaboratively with clients enable to successful execution of your drug development program. We can advise and author the pre-IND meeting request and briefing book to prepare for FDA pre-IND meetings and attend FDA meetings.
Keystone Biologics Advisory works collaboratively with clients to prepare for FDA pre-IND meetings. Our involvement includes understanding the drug development program, review of CMC documentation in relation to regulatory readiness, advising on the critical issues to address with the FDA and regulatory strategy. This ensures the timely and strategic engagement with the FDA to prepare for pre-IND meeting.
Keystone Biologics Advisory works collaboratively with clients enable to successful execution of your drug development program. We can advise and author the pre-IND meeting request and briefing book to prepare for FDA pre-IND meetings and attend FDA meetings.
